Expert Insights on Hodgkin’s Lymphoma Development in an Activated PI3K Delta Syndrome Patient Undergoing Leniolisib Treatment
FRONTIERS IN IMMUNOLOGY（2025）
Key words
activated PI3K delta syndrome (APDS),leniolisib,Hodgkin (cHL),PI3K inhibitor,Hodgkin lymphoma (HL)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined